Jan. 27 at 2:29 PM
$CNMD "Heads up alert! Only three days until Upcoming earnings on Wednesday, 1/28/2026 for
$CNMD
Bearish (2.5)
CONMED Corporation (NYSE: CNMD) is experiencing a challenging period, as reflected in its recent stock performance and mixed analyst sentiments.
The company's stock has seen a notable decline of approximately 20.6% over the past six months, currently trading at around
$42.52, which is significantly underperforming compared to the S&P 500's 11.1% rise.
Key financial metrics indicate a P/E ratio of approximately 25, which is slightly above the industry average of 22, suggesting that the stock may be overvalued relative to its peers.
Furthermore, the company has reaffirmed its revenue and earnings guidance for 2025, yet the uncertainty surrounding the CFO transition and recent stock volatility raises concerns among investors.
Analysts project modest EPS growth of around 5% annually, while revenue is expected to grow at a rate of 6% over the next few years, which, while positive, may not be sufficient to restore investor confidence.
Comparatively, CNMD's total shareholder return over the past year stands at 37%, which, while positive, is overshadowed by the recent downturn.
Looking ahead, CONMED is set to announce its fourth-quarter financial results on January 28, 2026.
Analysts are cautiously optimistic, with consensus estimates suggesting an EPS of
$0.55, reflecting a slight decline from the previous quarter.
Historical performance indicates that the company has often exceeded analyst expectations, but the current market environment and internal transitions may dampen this potential.
The upcoming earnings report will be crucial, as it could either reaffirm the company’s guidance or highlight ongoing challenges, impacting the stock's trajectory significantly.
In terms of sector performance, the surgical equipment and consumables industry has shown resilience, with a general upward trend driven by increasing demand for medical devices and advancements in technology.
However, CONMED's specific challenges, including recent leadership changes and market competition, suggest a more cautious outlook for the company relative to its peers.
Overall, while the industry remains robust, CONMED's current position warrants careful monitoring as it navigates these turbulent waters.
- Funds were net buyers of
$CNMD during the previous reporting quarter.
- Funds with large holdings in
$CNMD include:
- Deerfield Management Co, MV:
$36MM. Fund Rank: 86%
www.deerfield.com
- Invenomic Capital Management LP, MV:
$20MM. New position. Fund Rank: 53%
www.invenomic.com
- Holocene Advisors LP, MV:
$2MM. Fund Rank: 84%
www.holoceneadvisors.com
- Last 10 days performance: -3%
- Last 30 days performance: 4%
- Last 90 days performance: -14%
Some of the latest news articles:
- Title: Surgical Equipment & Consumables - Diversified Stocks Q3 Results: Benchmarking CONMED (NYSE:CNMD)
Publication Date: 1/14/2026 3:35:03 AM, Source: yahoo
URL: https://finance.yahoo.com/news/surgical-equipment-consumables-diversified-stocks-033503699.html?.tsrc=rss
- Title: 3 Reasons to Sell CNMD and 1 Stock to Buy Instead
Publication Date: 1/13/2026 4:05:16 AM, Source: yahoo
URL: https://finance.yahoo.com/news/3-reasons-sell-cnmd-1-040516629.html?.tsrc=rss
- Title: 3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
Publication Date: 1/10/2026 4:00:57 AM, Source: yahoo
URL: https://finance.yahoo.com/news/3-reasons-avoid-cnmd-1-040057592.html?.tsrc=rss
- Title: A Look At CONMED (CNMD) Valuation After CFO Transition Plans And 2025 Guidance Reaffirmation
Publication Date: 1/10/2026 1:15:40 AM, Source: yahoo
URL: https://finance.yahoo.com/news/look-conmed-cnmd-valuation-cfo-011540125.html?.tsrc=rss
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."
